Mannatech Appoints Kevin Robbins to Board of Directors
December 08 2016 - 4:12PM
Business Wire
Mannatech®, Incorporated (NASDAQ: MTEX) (“Mannatech”), a global
health and wellness company committed to transforming lives to make
a better world, today announced the appointment of Kevin Robbins to
its Board of Directors.
“Kevin brings to the Board 22 years of invaluable Mannatech
field experience and perspective as well as extensive service as a
leader of our independent sales Associates,” said J. Stanley
Fredrick, Chairman of the Board of Mannatech. “We are proud to
continue the legacy of having field representation on the Board.
Kevin’s unique knowledge about how we work with our Associates and
customers helps make him a valued asset and member of Mannatech’s
Board of Directors.”
Robbins, son of Mannatech co-founder Ray Robbins, began his part
time Mannatech career in 1994. By 1996, Kevin was able to dedicate
his career to Mannatech full time. In 2003, he was awarded as the
global recipient of the Ray Robbins Giving Spirit Award. Then, in
2012, Kevin was recognized as one of the Top Global Business
Builders of the Year.
Robbins has been a leader for Mannatech since 2000, when he was
elected to represent Mannatech’s North America field as part of the
North American Advisory Council. He originally served five years on
the advisory council, and was later re-elected for another
three-year term. As part of the advisory council, Kevin served as
Chairman for five years where he worked closely with the company to
develop new compensation plans, new incentive trips and training
programs with respect to independent sales Associates in North
America.
Robbins earned a Bachelor of Business Administration in
Marketing at The University of Texas at Arlington.
About Mannatech
Mannatech offers a profound wellness experience through a
financially rewarding opportunity that makes a difference in the
lives of people across the world. Through its innovative
Glyconutrition products, Mannatech changes lives, providing an
unprecedented level of natural wellness*, freedom and purpose. With
more than 20 years of experience and operations in 25 countries,
Mannatech is committed to changing lives. For more information,
visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements generally can be identified by use
of phrases or terminology such as “intend” or other similar words
or the negative of such terminology. Similarly, descriptions of
Mannatech’s objectives, strategies, plans, goals or targets
contained herein are also considered forward-looking statements.
Mannatech believes this release should be read in conjunction with
all of its filings with the United States Securities and Exchange
Commission and cautions its readers that these forward-looking
statements are subject to certain events, risks, uncertainties and
other factors. Some of these factors include, among others,
Mannatech’s inability to attract and retain associates and members,
increases in competition, litigation, regulatory changes and its
planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each
forward-looking statement in this release, as well as those set
forth in its latest Annual Report on Form 10-K and Quarterly Report
on Form 10-Q, and other filings filed with the United States
Securities and Exchange Commission, including its current reports
on Form 8-K. All of the forward-looking statements contained herein
speak only as of the date of this release.
*These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161208006227/en/
Mannatech, IncorporatedKalyn Dabbs,
972-471-7245pr@mannatech.com
Mannatech (NASDAQ:MTEX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mannatech (NASDAQ:MTEX)
Historical Stock Chart
From Apr 2023 to Apr 2024